Immunologic cell features in lymphocytic leukemias: a review.

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Chronic Lymphocytic Leukemia (CLL) is primarily defined by the proliferation of abnormal B-lymphocytes.
• T-cell populations in CLL patients typically appear normal, with absolute counts potentially exceeding normal levels.
• Evidence supports a clonal origin for B-lymphocytes in CLL, indicated by single Ig light chain expression and identical serum idiotype.

Purpose of the Study:

• To elucidate the characteristics of B-lymphocyte abnormalities in Chronic Lymphocytic Leukemia (CLL).
• To investigate the implications of these abnormalities on cell behavior and disease pathogenesis.
• To support the theory of abnormal B-cell clone expansion in CLL.

Main Methods:

• Analysis of B-lymphocyte surface markers, including immunoglobulin (Ig) fluorescence intensity.
• Assessment of Fc-receptor and C3b-receptor expression on lymphocytes.
• Evaluation of C3d-receptor presence and comparison with C3b-receptor frequency.
• Investigation of peripheral blood B-lymphocyte traffic capacity.

Main Results:

• Reduced and variable surface Ig fluorescence intensity on B-lymphocytes in CLL patients compared to normal subjects.
• Absence or reduced expression of Fc-receptors and C3b-receptors on CLL B-lymphocytes.
• Significant differences in C3b-receptor frequency compared to C3d-receptor, unlike normal lymphocytes.
• Defective traffic capacity of peripheral blood B-lymphocytes in CLL patients.

Conclusions:

• CLL is predominantly caused by the expansion of an abnormal B-cell clone.
• These abnormal B-cells are arrested in their maturational development.
• Accumulation in peripheral blood is attributed to impaired traffic and non-responsiveness to stimulation.